{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T03:05:48Z","timestamp":1740107148296,"version":"3.37.3"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2021,11,9]],"date-time":"2021-11-09T00:00:00Z","timestamp":1636416000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2021,11,9]],"date-time":"2021-11-09T00:00:00Z","timestamp":1636416000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Dermatol Res"],"DOI":"10.1007\/s00403-021-02297-w","type":"journal-article","created":{"date-parts":[[2021,11,9]],"date-time":"2021-11-09T12:03:02Z","timestamp":1636459382000},"page":"249-257","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Comparative study of doxycycline, sancycline, and 4-dedimethylamino sancycline (CMT-3) on epidermal melanogenesis"],"prefix":"10.1007","volume":"315","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5760-6669","authenticated-orcid":false,"given":"Shilpi","family":"Goenka","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanford R.","family":"Simon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,11,9]]},"reference":[{"issue":"7130","key":"2297_CR1","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1038\/nature05660","volume":"445","author":"JY Lin","year":"2007","unstructured":"Lin JY, Fisher DE (2007) Melanocyte biology and skin pigmentation. Nature 445(7130):843\u2013850","journal-title":"Nature"},{"issue":"7","key":"2297_CR2","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1016\/j.biocel.2010.03.023","volume":"42","author":"MV Schiaffino","year":"2010","unstructured":"Schiaffino MV (2010) Signaling pathways in melanosome biogenesis and pathology. Int J Biochem Cell Biol 42(7):1094\u20131104","journal-title":"Int J Biochem Cell Biol"},{"issue":"6","key":"2297_CR3","doi-asserted-by":"publisher","first-page":"2440","DOI":"10.3390\/ijms10062440","volume":"10","author":"T-S Chang","year":"2009","unstructured":"Chang T-S (2009) An updated review of tyrosinase inhibitors. Int J Mol Sci 10(6):2440\u20132475","journal-title":"Int J Mol Sci"},{"issue":"6","key":"2297_CR4","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1111\/j.1600-0749.2006.00334.x","volume":"19","author":"F Solano","year":"2006","unstructured":"Solano F et al (2006) Hypopigmenting agents: an updated review on biological, chemical and clinical aspects. Pigment Cell Res 19(6):550\u2013571","journal-title":"Pigment Cell Res"},{"issue":"3","key":"2297_CR5","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1111\/j.1365-2230.2006.02128.x","volume":"31","author":"G Millington","year":"2006","unstructured":"Millington G (2006) Proopiomelanocortin (POMC): the cutaneous roles of its melanocortin products and receptors. Clin Exp Dermatol Clin Dermatol 31(3):407\u2013412","journal-title":"Clin Exp Dermatol Clin Dermatol"},{"issue":"3","key":"2297_CR6","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.1610-0387.2009.07137_supp.x","volume":"8","author":"SK Fistarol","year":"2010","unstructured":"Fistarol SK, Itin PH (2010) Disorders of pigmentation. JDDG Journal der Deutschen Dermatologischen Gesellschaft 8(3):187\u2013202","journal-title":"JDDG Journal der Deutschen Dermatologischen Gesellschaft"},{"issue":"2","key":"2297_CR7","doi-asserted-by":"publisher","first-page":"87","DOI":"10.2165\/11536930-000000000-00000","volume":"12","author":"VD Callender","year":"2011","unstructured":"Callender VD et al (2011) Postinflammatory hyperpigmentation. Am J Clin Dermatol 12(2):87\u201399","journal-title":"Am J Clin Dermatol"},{"issue":"3","key":"2297_CR8","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1111\/1346-8138.14172","volume":"45","author":"MB Maymone","year":"2018","unstructured":"Maymone MB et al (2018) Correlating the dermatology life quality index and skin discoloration impact evaluation questionnaire tools in disorders of hyperpigmentation. J Dermatol 45(3):361\u2013362","journal-title":"J Dermatol"},{"key":"2297_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ceb.2014.02.003","volume":"29","author":"X Wu","year":"2014","unstructured":"Wu X, Hammer JA (2014) Melanosome transfer: it is best to give and receive. Curr Opin Cell Biol 29:1\u20137","journal-title":"Curr Opin Cell Biol"},{"issue":"4","key":"2297_CR10","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.1038\/jid.2011.413","volume":"132","author":"H Ando","year":"2012","unstructured":"Ando H et al (2012) Melanosomes are transferred from melanocytes to keratinocytes through the processes of packaging, release, uptake, and dispersion. J Investig Dermatol 132(4):1222\u20131229","journal-title":"J Investig Dermatol"},{"key":"2297_CR11","first-page":"89","volume-title":"Chemically modified tetracyclines. Periodontology and dental implantology","author":"A Sawhney","year":"2019","unstructured":"Sawhney A (2019) Chemically modified tetracyclines. Periodontology and dental implantology. IntechOpen, London, p 89"},{"issue":"8","key":"2297_CR12","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1177\/00220345870660080401","volume":"66","author":"LM Golub","year":"1987","unstructured":"Golub LM et al (1987) A non-antibacterial chemically-modified tetracycline inhibits mammalian collagenase activity. J Dent Res 66(8):1310\u20131314","journal-title":"J Dent Res"},{"issue":"5","key":"2297_CR13","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1128\/AAC.46.5.1447-1454.2002","volume":"46","author":"Y Liu","year":"2002","unstructured":"Liu Y et al (2002) A chemically modified tetracycline (CMT-3) is a new antifungal agent. Antimicrob Agents Chemother 46(5):1447\u20131454","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"2297_CR14","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/j.phrs.2011.05.011","volume":"64","author":"Y Gu","year":"2011","unstructured":"Gu Y et al (2011) Chemically modified tetracycline-3 (CMT-3): a novel inhibitor of the serine proteinase, elastase. Pharmacol Res 64(6):595\u2013601","journal-title":"Pharmacol Res"},{"issue":"6","key":"2297_CR15","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1080\/07853890500300386","volume":"37","author":"Y Gu","year":"2005","unstructured":"Gu Y et al (2005) Inhibition of breast cancer cell extracellular matrix degradative activity by chemically modified tetracyclines. Ann Med 37(6):450\u2013460","journal-title":"Ann Med"},{"issue":"4","key":"2297_CR16","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1016\/S0002-9440(10)63512-2","volume":"163","author":"MM Islam","year":"2003","unstructured":"Islam MM et al (2003) A nonantibiotic chemically modified tetracycline (CMT-3) inhibits intimal thickening. Am J Pathol 163(4):1557\u20131566","journal-title":"Am J Pathol"},{"issue":"4","key":"2297_CR17","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1097\/SHK.0b013e318245f2f9","volume":"37","author":"SK Roy","year":"2012","unstructured":"Roy SK et al (2012) Chemically modified tetracycline 3 prevents acute respiratory distress syndrome in a porcine model of sepsis + ischemia\/reperfusion-induced lung injury. Shock 37(4):424\u2013432","journal-title":"Shock"},{"issue":"3","key":"2297_CR18","doi-asserted-by":"publisher","first-page":"257","DOI":"10.2174\/0929867013373660","volume":"8","author":"HM Lee","year":"2001","unstructured":"Lee HM et al (2001) CMT-3, a non-antimicrobial tetracycline (TC), inhibits MT1-MMP activity: relevance to cancer. Curr Med Chem 8(3):257\u2013260","journal-title":"Curr Med Chem"},{"issue":"3","key":"2297_CR19","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1111\/idj.12221","volume":"66","author":"LM Golub","year":"2016","unstructured":"Golub LM et al (2016) Non-antibacterial tetracycline formulations: host-modulators in the treatment of periodontitis and relevant systemic diseases. Int Dent J 66(3):127\u2013135","journal-title":"Int Dent J"},{"issue":"9","key":"2297_CR20","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1200\/JCO.2005.04.2614","volume":"24","author":"BJ Dezube","year":"2006","unstructured":"Dezube BJ et al (2006) Randomized phase II trial of matrix metalloproteinase inhibitor COL-3 in AIDS-related Kaposi\u2019s sarcoma: an AIDS malignancy consortium study. J Clin Oncol 24(9):1389\u20131394","journal-title":"J Clin Oncol"},{"key":"2297_CR21","unstructured":"Ryan M et al. (2008) Effects of short-term COL-3 on local biomarkers of periodontitis. J Dent Res 87(special issue A) abstract # 0040"},{"issue":"10","key":"2297_CR22","doi-asserted-by":"publisher","first-page":"411","DOI":"10.3390\/biomedicines8100411","volume":"8","author":"S Goenka","year":"2020","unstructured":"Goenka S, Simon SR (2020) CMT-308, a Nonantimicrobial chemically-modified tetracycline, exhibits anti-melanogenic activity by suppression of melanosome export. Biomedicines 8(10):411","journal-title":"Biomedicines"},{"issue":"3","key":"2297_CR23","doi-asserted-by":"publisher","first-page":"61","DOI":"10.3390\/cosmetics7030061","volume":"7","author":"S Goenka","year":"2020","unstructured":"Goenka S, Simon SR (2020) Inhibitory effects of the bioactive thermorubin isolated from the fungus Thermoactinomyces Antibioticus on Melanogenesis. Cosmetics 7(3):61","journal-title":"Cosmetics"},{"issue":"1","key":"2297_CR24","first-page":"37","volume":"73","author":"SP Keijmel","year":"2015","unstructured":"Keijmel SP et al (2015) Cutaneous hyperpigmentation induced by doxycycline: a case series. Neth J Med 73(1):37\u201340","journal-title":"Neth J Med"},{"issue":"3","key":"2297_CR25","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1097\/00000372-200606000-00049","volume":"28","author":"R Pichardo","year":"2006","unstructured":"Pichardo R, Yeatts R, Sangueza O (2006) Doxycycline-inducted cutaneous hyperpigmentation. Am J Dermatopathol 28(3):235","journal-title":"Am J Dermatopathol"},{"issue":"10","key":"2297_CR26","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1111\/j.1365-4632.2006.02946.x","volume":"45","author":"E Adisen","year":"2006","unstructured":"Adisen E, Gurer MA, Erdem O (2006) Tetracycline\/doxycycline-induced cutaneous depressed pigmentation. Int J Dermatol 45(10):1245\u20131247","journal-title":"Int J Dermatol"},{"issue":"3","key":"2297_CR27","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1016\/j.jep.2011.07.050","volume":"137","author":"YY Chan","year":"2011","unstructured":"Chan YY, Kim KH, Cheah SH (2011) Inhibitory effects of Sargassum polycystum on tyrosinase activity and melanin formation in B16F10 murine melanoma cells. J Ethnopharmacol 137(3):1183\u20131188","journal-title":"J Ethnopharmacol"},{"issue":"6","key":"2297_CR28","first-page":"1003","volume":"28","author":"M-O Sim","year":"2017","unstructured":"Sim M-O et al (2017) Anti-melanogenesis and anti-oxidant of Salix pseudo-lasiogyne water extract in \u03b1-MSH-induced B16F10 melanoma cells. Food Hydrocoll 28(6):1003\u20131016","journal-title":"Food Hydrocoll"},{"issue":"1","key":"2297_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-018-37055-y","volume":"9","author":"S Chung","year":"2019","unstructured":"Chung S, Lim GJ, Lee JY (2019) Quantitative analysis of melanin content in a three-dimensional melanoma cell culture. Sci Rep 9(1):1\u20139","journal-title":"Sci Rep"},{"issue":"1","key":"2297_CR30","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.jdermsci.2019.03.004","volume":"94","author":"T Fu","year":"2019","unstructured":"Fu T et al (2019) Fargesin inhibits melanin synthesis in murine malignant and immortalized melanocytes by regulating PKA\/CREB and P38\/MAPK signaling pathways. J Dermatol Sci 94(1):213\u2013219","journal-title":"J Dermatol Sci"},{"issue":"2","key":"2297_CR31","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/0303-7207(95)03708-X","volume":"116","author":"G Hunt","year":"1996","unstructured":"Hunt G, Todd C, Thody AJ (1996) Unresponsiveness of human epidermal melanocytes to melanocyte-stimulating hormone and its association with red hair. Mol Cell Endocrinol 116(2):131\u2013136","journal-title":"Mol Cell Endocrinol"},{"issue":"10","key":"2297_CR32","doi-asserted-by":"publisher","first-page":"e109398","DOI":"10.1371\/journal.pone.0109398","volume":"9","author":"L Qin","year":"2014","unstructured":"Qin L et al (2014) Dual effects of alpha-arbutin on monophenolase and diphenolase activities of mushroom tyrosinase. PLoS ONE 9(10):e109398","journal-title":"PLoS ONE"},{"issue":"12","key":"2297_CR33","doi-asserted-by":"publisher","first-page":"2146","DOI":"10.1007\/s11947-017-1976-2","volume":"10","author":"K Chen","year":"2017","unstructured":"Chen K et al (2017) A novel inhibitor against mushroom tyrosinase with a double action mode and its application in controlling the browning of potato. Food Bioprocess Technol 10(12):2146\u20132155","journal-title":"Food Bioprocess Technol"},{"issue":"3\u20134","key":"2297_CR34","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1515\/znc-2007-3-412","volume":"62","author":"S Tamura","year":"2007","unstructured":"Tamura S, Nitoda T, Kubo I (2007) Effects of salicylic acid on mushroom tyrosinase and B16 melanoma cells. Zeitschrift f\u00fcr Naturforschung C 62(3\u20134):227\u2013233","journal-title":"Zeitschrift f\u00fcr Naturforschung C"},{"issue":"18","key":"2297_CR35","doi-asserted-by":"publisher","first-page":"3407","DOI":"10.1128\/MCB.00106-14","volume":"34","author":"Q Jian","year":"2014","unstructured":"Jian Q et al (2014) MicroRNA 340 is involved in UVB-induced dendrite formation through the regulation of RhoA expression in melanocytes. Mol Cell Biol 34(18):3407\u20133420","journal-title":"Mol Cell Biol"},{"issue":"6","key":"2297_CR36","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1111\/php.12497","volume":"91","author":"J Rok","year":"2015","unstructured":"Rok J et al (2015) Modulation of melanogenesis and antioxidant status of melanocytes in response to phototoxic action of doxycycline. Photochem Photobiol 91(6):1429\u20131434","journal-title":"Photochem Photobiol"},{"issue":"3","key":"2297_CR37","doi-asserted-by":"publisher","first-page":"271","DOI":"10.2174\/0929867013373516","volume":"8","author":"BL Lokeshwar","year":"2001","unstructured":"Lokeshwar BL, Escatel E, Zhu B (2001) Cytotoxic activity and inhibition of tumor cell invasion by derivatives of a chemically modified tetracycline CMT-3 (COL-3). Curr Med Chem 8(3):271\u2013279","journal-title":"Curr Med Chem"},{"key":"2297_CR38","doi-asserted-by":"publisher","first-page":"104790","DOI":"10.1016\/j.tiv.2020.104790","volume":"65","author":"J Rok","year":"2020","unstructured":"Rok J et al (2020) Cytotoxic and proapoptotic effect of doxycycline\u2013an in vitro study on the human skin melanoma cells. Toxicol In Vitro 65:104790","journal-title":"Toxicol In Vitro"},{"issue":"7","key":"2297_CR39","doi-asserted-by":"publisher","first-page":"3755","DOI":"10.3390\/ijms22073755","volume":"22","author":"Z Rzepka","year":"2021","unstructured":"Rzepka Z et al (2021) Molecular and biochemical basis of minocycline-induced hyperpigmentation\u2014the study on normal human melanocytes exposed to UVA and UVB radiation. Int J Mol Sci 22(7):3755","journal-title":"Int J Mol Sci"},{"issue":"3","key":"2297_CR40","doi-asserted-by":"publisher","first-page":"24063","DOI":"10.3402\/jchimp.v4.24063","volume":"4","author":"V Fiscus","year":"2014","unstructured":"Fiscus V, Hankinson A, Alweis R (2014) Minocycline-induced hyperpigmentation. J Commun Hosp Intern Med Perspect 4(3):24063","journal-title":"J Commun Hosp Intern Med Perspect"},{"issue":"6","key":"2297_CR41","doi-asserted-by":"publisher","first-page":"e244365","DOI":"10.1136\/bcr-2021-244365","volume":"14","author":"N Yamamoto","year":"2021","unstructured":"Yamamoto N, Dejima A, Hasatani K (2021) Minocycline-induced hyperpigmentation in a patient with prurigo pigmentosa. BMJ Case Rep 14(6):e244365","journal-title":"BMJ Case Rep"},{"issue":"5","key":"2297_CR42","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1034\/j.1600-0749.2002.02056.x","volume":"15","author":"G Scott","year":"2002","unstructured":"Scott G (2002) Rac and rho: the story behind melanocyte dendrite formation. Pigment Cell Res 15(5):322\u2013330","journal-title":"Pigment Cell Res"},{"issue":"1\u20132","key":"2297_CR43","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/S0378-5173(01)00988-7","volume":"235","author":"TP Banning","year":"2002","unstructured":"Banning TP, Heard CM (2002) Binding of doxycycline to keratin, melanin and human epidermal tissue. Int J Pharm 235(1\u20132):219\u2013227","journal-title":"Int J Pharm"},{"key":"2297_CR44","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.cbi.2019.02.005","volume":"303","author":"J Rok","year":"2019","unstructured":"Rok J et al (2019) Chlortetracycline and melanin biopolymer\u2013The risk of accumulation and implications for phototoxicity: an in vitro study on normal human melanocytes. Chem Biol Interact 303:27\u201334","journal-title":"Chem Biol Interact"},{"issue":"1\u20132","key":"2297_CR45","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.ijpharm.2013.04.021","volume":"450","author":"X Yang","year":"2013","unstructured":"Yang X et al (2013) Preparation and characterization of 4-dedimethylamino sancycline (CMT-3) loaded nanostructured lipid carrier (CMT-3\/NLC) formulations. Int J Pharm 450(1\u20132):225\u2013234","journal-title":"Int J Pharm"}],"container-title":["Archives of Dermatological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-021-02297-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00403-021-02297-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-021-02297-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,20]],"date-time":"2023-02-20T02:26:21Z","timestamp":1676859981000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00403-021-02297-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,9]]},"references-count":45,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2023,3]]}},"alternative-id":["2297"],"URL":"https:\/\/doi.org\/10.1007\/s00403-021-02297-w","relation":{},"ISSN":["1432-069X"],"issn-type":[{"type":"electronic","value":"1432-069X"}],"subject":[],"published":{"date-parts":[[2021,11,9]]},"assertion":[{"value":"29 November 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 October 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 October 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 November 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that there are no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studies involving animals or human participants.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}